Femtobiomed Inc. (XKON:327610)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,320.00
-70.00 (-1.30%)
Feb 27, 2025, 9:00 AM KST
-40.76%
Market Cap 43.70B
Revenue n/a
Net Income n/a
Shares Out 8.26M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 801
Average Volume 3,798
Open 4,605.00
Previous Close 5,390.00
Day's Range 4,605.00 - 5,320.00
52-Week Range 4,510.00 - 10,000.00
Beta 0.98
RSI 44.91
Earnings Date n/a

About Femtobiomed

Femtobiomed Inc. engages in the development of cargo-free intracellular delivery platform. The company, through its platform, CELLSHOT, is working on cell-based therapeutic pipelines. Its platform provides unprecedented approaches to cell therapeutics and cell biology research. The company was founded in 2011 and is based in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2011
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 327610
Full Company Profile

News

There is no news available yet.